Barely Significant
← all excerpts

Eculizumab therapy leads to rapid resolution of thrombocytopenia in atypical hemolytic uremic syndrome.

Adv Hematol · 2014 · PMC4221969 · PMID 25400666

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantP ≤ 0.001actually significant
The difference in the platelet count response between the groups with and without concurrent plasma exchange was highly significant ( P ≤ 0.001 by Fisher's exact test). 4.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.